Author

R. Skrabana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Kovacech· 2 shared M. Zilkova· 2 shared A. Kovac· 1 shared A. L. Bula· 1 shared A. Lends· 1 shared A. Ohradanova-Repic· 1 shared B. Brejova· 1 shared B. Klempa· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

B. Kovacech

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

dGAE(297-391) tau fragment promotes formation of CTE-like full-length tau filaments

K. Kitoka, A. Lends, G. Kucinskas, A. L. Bula, L. Krasauskas, V. Smirnovas, M. Zilkova, B. Kovacech, R. Skrabana, J. Hritz, K. Jaudzems

The paper shows that the dGAE tau fragment seeds the formation of CTE-like full-length tau filaments in vitro.

bioRxiv · Feb 1, 2023 · PreprintBiophysics

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin

A. Ohradanova-Repic, L. Gebetsberger, G. Tajti, G. Ondrovicova, R. Prazenicova, R. Skrabana, P. Barath, H. Stockinger, V. Leksa

This study identifies a lactoferrin-derived peptide that inhibits TMPRSS2-mediated SARS-CoV-2 spike protein processing and viral infection.

bioRxiv · Dec 20, 2021Immunology

Second Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of Concern

B. Kovacech, L. Fialova, P. Filipcik, M. Zilkova, R. Skrabana, N. Paulenka-Ivanovova, A. Kovac, D. Palova, G. Paulikova Rolkova, K. Tomkova, N. Turic Csokova, K. Markova, M. Skrabanova, K. Sinska, N. Basheer, , E. Kontsekova

The paper develops two monoclonal antibodies that neutralize emerging SARS-CoV-2 variants and prevent escape mutations.

bioRxiv · Jun 9, 2021 · PreprintMicrobiology